EFTA01841591.pdf

To: m [email protected]] From: Sent: Thur 2/9/2012 12:31:10 PM Subject: Re: Hi Jeffrey can set set an approximate time? Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston. MA 02215 Phone: Email: Web: www.proqraminplacebostudies.orq On Feb 7, 2012, at 2:27 PM, Jeffrey Epstein wrote: ped martin novak On Tue, Feb 7, 2012 at 3:25 PM, ‹ > wrote: what time? any office # at I Brattle Sq. tcd Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA 02215 Phone: Email: tkaptchuAbidmc harvard.edu Web: www.prooraminplacebostudies.orq EFTA_R1_00227988 EFTA01841591 On Feb 7, 2012, at 2:22 PM, Jeffrey Epstein wrote: 1 brattle square On Tue, Feb 7, 2012 at 3:12 PM, e > wrote: Jeffrey, I think it may be a good idea to set up a time to meet on April 12 in Cambridge. As a location, I can offer my home office near Harvard Sq, my office at the medical school, or any tea shop in the area. Or do you have another preference? Suggest a time as I'm flexible that day. tcd Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston. MA 02215 Phone: Email: Web: www.programinplacebostudies.org On Feb 6, 2012, at 5:53 PM, Jeffrey Epstein wrote: cambridge april 12, but phone availble before On Mon, Feb 6, 2012 at 5:15 PM, e > wrote: Hi Jeffrey, When is a good time to talk about placebo? When are you next in Cambridge? EFTA_R1_00227989 EFTA01841592 ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA 0221 Phone: Email: Web: wwvv.procirammplacebostudies.orq On Jan 13, 2012, at 3:15 PM, Jeffrey Epstein wrote: Im in africa until the 27th On Fri, Jan 13, 2012 at 9:05 PM, wrote: Hi Jeff, I'm around Monday, Martin Luther King day until 3pm. Is that a good day for a phone conversation? Alternatively, as the phone hasn't been too successful, should we meet in person? When are you in Cambridge next? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 EFTA_R1_00227990 EFTA01841593  Phone: Email: tkaptchuAbidmc.harvard.edu Web: www.programinplacebostudies.org On Dec 25, 2011, at 1:31 PM, Jeffrey Epstein wrote: lets alk on tues On Sun, Dec 25, 2011 at 2:04 PM, wrote: Is there a good time to check-in with you to get your feedback on the budget we sent you two weeks ago and on what issues would interest you in developing a partnership with our efforts in placebo studies? Were trying to think bot scientifically and strategically. Our team has all the intellectual and infrastructure resources of Harvard University and any input would be appreciated. Best, ted EFTA_R1_00227991 EFTA01841594  Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston. MA 02215 Phone: Email: Web: www programinplacebostudies.org On Dec 5, 2011, at 2:41 PM, Jeffrey Epstein wrote: now? a On Mon, Dec 5, 2011 at 1:26 PM, wrote: I tried calling you on November 28. No answer. Our work is getting enormous media attention. (Attached is an article in this week's New Yorker. I wished it had focused more on our science and less on me. We expect coverage by EFTA_R1_00227992 EFTA01841595  "60 Minutes" in January.) This is a critical time to develop our scientific and institutional roots at Harvard. We're looking for partners to help move our research along. Would there be another time you could talk by telephone? Best ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA 02215 Phone: Email: Web: v, v14/ v, programitiplacebostuciies org *********************************************** ************ EFTA_R1_00227993 EFTA01841596 The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return c-mail or by e-mail to [email protected] and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved **************************************************** ******* The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. if you have received this communication in error, please notify us immediately by return c-mail or by e-mail to jeevacati n mail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved ********************************************************* sa The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited EFTA_R1_00227994 EFTA01841597 and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by c-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved *********************************************************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved *********************************************************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00227995 EFTA01841598 The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to Lees [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00227996 EFTA01841599